In the economic analysis of the REVISE trial (E-REVISE), the incremental cost of randomization to IV pantoprazole (Protonix ...

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis. Objectives: To estimate the ...

New research shows that a low-cost medication can prevent serious complications in ventilated ICU patients while also saving ...

During a session at the Annual Meeting of the American College of Rheumatology, Jeffrey Curtis, MD, discussed the ways in which patients with rheumatoid arthritis who demonstrate a less-than-adequate ...

Salpingectomy for permanent contraception yields an incremental cost-effectiveness ratio of $143,769 per quality-adjusted life-year (QALY) gained compared with vasectomy. The procedure prevents 6085 ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

Characterizing Opioid Prescribing Trends of Medical Oncologists From 2013 to 2019: Analysis From the Centers for Medicare & Medicaid Services Medicare Part D Prescribers Database This work supported ...

Current guidelines for genetic testing in women with breast cancer are based on established family history or clinical guidelines but miss approximately 50% of carriers who fall below the clinical ...

A study led by McMaster University researchers shows that a widely available and inexpensive medication not only prevents ...

BOSTON, MA - JUNE 6: Steven Pearson, President of the Institute for Clinical and Economic Review (ICER), talks with chief medical officer David Rind during a meeting at their offices in Boston on June ...